Quantum量子訊息有限公司

AI-ECG Analysis & Screening Software Market

完整報告名稱與涵蓋範圍
AI-ECG Analysis & Screening Software Market Size, Share & Trends Analysis Report, By Software Type (Arrhythmia Detection and Rhythm Interpretation Algorithms, AI-ECG Screening for Structural and Functional Heart Disease, Cloud Platforms and Workflow Integration Software, Wearable and Consumer-Connected ECG Applications), By Deployment (Cloud-Based, On-Premise and Device-Embedded), By Application (Atrial Fibrillation and Arrhythmia Screening, Low Ejection Fraction, Cardiomyopathy and Valve Disease Detection, Acute Coronary Syndrome and Emergency Triage, Population and Primary Care Screening), By End User, By Region, and Segment Forecasts, 2026-2035

報告摘要

The AI-ECG analysis and screening software market covers algorithms and platforms that interpret electrocardiograms using machine learning to detect arrhythmias, screen for structural and functional heart disease such as low ejection fraction and cardiomyopathy, triage acute coronary syndromes and support population screening, delivered through cloud, on-premise and device-embedded deployments. ECG hardware and cardiac monitoring services are excluded except where software is sold or licensed separately. The field has moved beyond automated rhythm interpretation to algorithms that extract signals invisible to human readers, enabling twelve-lead and single-lead ECGs to flag reduced ejection fraction, hypertrophic cardiomyopathy, valvular disease and electrolyte abnormalities, with regulatory clearances and prospective trials validating clinical impact. Adoption is driven by workforce shortages in cardiology, the volume of ECGs generated by wearables and monitoring patches and the economics of using an inexpensive test to prioritise echocardiography and specialist referral. Vendors differentiate on validated indications, integration with ECG carts, electronic health records and telehealth workflows, and on reimbursement, with new billing codes for AI-enabled screening emerging in the United States. North America leads adoption and reimbursement development, with Europe, Japan, South Korea and India expanding through health system pilots and wearable ecosystems. Competition involves digital cardiology specialists, monitoring companies, ECG hardware manufacturers, academic licensors and consumer electronics platforms. The InsightAce study provides US$ revenue forecasts for every software type, deployment, application and end user and regional segment over 2026-2035, plus segment trend analysis, competitive landscape mapping and profiles of leading participants.

授權報價

Single User$4,500 USD
Enterprise / Global Site Licence$9,500 USD

目錄 Table of Contents

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global AI-ECG Analysis & Screening Software Market Snapshot Chapter 4. Global AI-ECG Analysis & Screening Software Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Market Drivers 4.3. Market Challenges 4.4. Emerging Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis - Porter's Five Forces Analysis 4.7. Competitive Landscape and Market Positioning 4.8. Market Opportunity Analysis Chapter 5. Market Segmentation 1: By Software Type Estimates & Trend Analysis 5.1. Software Type & Market Share, 2026 & 2035 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Software Type: 5.2.1. Arrhythmia Detection and Rhythm Interpretation Algorithms 5.2.2. AI-ECG Screening for Structural and Functional Heart Disease 5.2.3. Cloud Platforms and Workflow Integration Software 5.2.4. Wearable and Consumer-Connected ECG Applications Chapter 6. Market Segmentation 2: By Deployment Estimates & Trend Analysis 6.1. Deployment & Market Share, 2026 & 2035 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Deployment: 6.2.1. Cloud-Based 6.2.2. On-Premise and Device-Embedded Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis 7.1. Application & Market Share, 2026 & 2035 7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application: 7.2.1. Atrial Fibrillation and Arrhythmia Screening 7.2.2. Low Ejection Fraction, Cardiomyopathy and Valve Disease Detection 7.2.3. Acute Coronary Syndrome and Emergency Triage 7.2.4. Population and Primary Care Screening Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis 8.1. End User & Market Share, 2026 & 2035 8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User: 8.2.1. Hospitals and Cardiology Practices 8.2.2. Primary Care and Telehealth Providers 8.2.3. Monitoring Service Providers and Device Manufacturers Chapter 9. AI-ECG Analysis & Screening Software Market: Regional Estimates & Trend Analysis 9.1. North America 9.1.1. United States 9.1.2. Canada 9.2. Europe 9.2.1. Germany 9.2.2. United Kingdom 9.2.3. France 9.2.4. Italy 9.2.5. Spain 9.2.6. Rest of Europe 9.3. Asia Pacific 9.3.1. China 9.3.2. Japan 9.3.3. India 9.3.4. South Korea 9.3.5. Australia 9.3.6. Southeast Asia 9.3.7. Rest of Asia Pacific 9.4. Latin America 9.4.1. Brazil 9.4.2. Mexico 9.4.3. Rest of Latin America 9.5. Middle East & Africa 9.5.1. GCC Countries 9.5.2. South Africa 9.5.3. Rest of Middle East & Africa Chapter 10. Competitive Landscape 10.1. Company Market Positioning Analysis 10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A) Chapter 11. Company Profiles 11.1. AliveCor, Inc. 11.2. Eko Health, Inc. 11.3. Philips (Cardiologs) 11.4. iRhythm Technologies, Inc. 11.5. Anumana, Inc. 11.6. Tempus AI, Inc. 11.7. Idoven 11.8. Powerful Medical 11.9. HeartBeam, Inc. 11.10. Cardiomatics 11.11. GE HealthCare Technologies Inc. 11.12. Nihon Kohden Corporation 11.13. Mayo Clinic Platform (AI-ECG Licensing) 11.14. Apple Inc. 11.15. Samsung Electronics Co., Ltd.

圖表清單 List of Tables & Figures

Table 1. Global AI-ECG Analysis & Screening Software Market Revenue Forecast by Software Type, 2026-2035 (US$ Mn) Figure 1. Global AI-ECG Analysis & Screening Software Market Segmentation Overview Table 2. Global AI-ECG Analysis & Screening Software Market Revenue Forecast by Deployment, 2026-2035 (US$ Mn) Figure 2. Global AI-ECG Analysis & Screening Software Market Share by Software Type, 2026 & 2035 Table 3. Global AI-ECG Analysis & Screening Software Market Revenue Forecast by Application, 2026-2035 (US$ Mn) Figure 3. AI-ECG Use Cases from Rhythm Interpretation to Structural Heart Disease Screening Table 4. Global AI-ECG Analysis & Screening Software Market Revenue Forecast by End User, 2026-2035 (US$ Mn) Figure 4. Global AI-ECG Analysis & Screening Software Market Share by Deployment, 2026 & 2035 Table 5. North America AI-ECG Analysis & Screening Software Market Revenue by Country, 2026-2035 (US$ Mn) Figure 5. Regulatory Clearances and Reimbursement Codes for AI-ECG Software by Region Table 6. Europe AI-ECG Analysis & Screening Software Market Revenue by Country, 2026-2035 (US$ Mn) Figure 6. Asia Pacific AI-ECG Analysis & Screening Software Growth Opportunity Analysis Table 7. Asia Pacific AI-ECG Analysis & Screening Software Market Revenue by Country, 2026-2035 (US$ Mn) Figure 7. Workflow Integration Points Across Wearables, ECG Carts and Electronic Health Records Table 8. Latin America AI-ECG Analysis & Screening Software Market Revenue by Country, 2026-2035 (US$ Mn) Figure 8. Competitive Positioning of Key AI-ECG Analysis & Screening Software Market Participants Table 9. Middle East & Africa AI-ECG Analysis & Screening Software Market Revenue by Country, 2026-2035 (US$ Mn)

提及公司

AliveCor, Inc.Eko Health, Inc.Philips (Cardiologs)iRhythm Technologies, Inc.Anumana, Inc.Tempus AI, Inc.IdovenPowerful MedicalHeartBeam, Inc.CardiomaticsGE HealthCare Technologies Inc.Nihon Kohden CorporationMayo Clinic Platform (AI-ECG Licensing)Apple Inc.Samsung Electronics Co., Ltd.

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們